ForumIAS LATEST
- 26 June | Read Less, Revise More: IFoS AIR 36 Nikhil's UPSC Strategy | Click Here to Watch →
- 27 June | How to Score 300+ in Philosophy Optional by Yogita Singh Dhami | Click Here to Watch →
- 28 June | Public Administration OGP Advanced Open Class by Ajeet Sir | Click Here to Watch →
News: India’s first COVID-19 vaccine candidate COVAXIN has received the approval of Drug Controller General of India(DCGI) for phase I and II of human clinical trials.
Facts:
- COVAXIN: It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus.
- Developed by: It has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
Additional Facts:
- DGCI: It is a department of the Central Drugs Standard Control Organization(CDSCO) responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids and vaccines in India.It comes under the Ministry of Health & Family Welfare.
